Jonathan Chang, Ph.D., CFA
Senior Managing Director, Emerging Oncology
Jonathan Chang, Ph.D., CFA is a Senior Research Analyst at SVB Securities covering Emerging Oncology. He has been an important contributor to the firm’s biotechnology research product and insights.
Jonathan joined the firm in 2013 as an Associate supporting the firm’s senior oncology biotechnology research team and in 2016, he assumed research coverage of several important emerging biotechnology companies. In 2018, he was named a Rising Star in Institutional Investor’s 2018 All-America Research Team for Biotechnology/Mid- & Small-Cap.
He earned a Ph.D. in Pharmacology from Cornell University, an M.A. in Biotechnology from Columbia University, and an Honors B.Sc. in Genes, Genetics, and Biotechnology from the University of Toronto. Dr. Chang is a CFA charter holder.